Health
·
Premium Times
·
WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus
The World Health Organization has recommended moving an Ebola vaccine targeting the Bundibugyo virus to a Phase III clinical trial, indicating support for wider testing of its effectiveness and safety against that strain of the disease.
Original story
Continue reading on Premium Times.
facts.ng aggregates publicly available headlines and provides AI-generated summaries. The original article is published by Premium Times; please visit them for the full report.